# NIH Reporter #5U54CA233444-09

Pilot Project 6

**Recipient:** University of Florida

**Award Amount:** $172,445.00
**Ceiling:** $172,445.00

**Awarded:** September 14, 2026

**Identifier:** 5U54CA233444-09

The project will evaluate novel compounds SYA013 and SYA014 in pancreatic cancer models, including drug-resistant models, organoids, and patient-derived xenografts, to investigate their anticancer activity and potential synergy with standard chemotherapy.

### Description

Funding for research into the therapeutic potential of SYA013 and SYA014, alone and in combination with gemcitabine or fluorouracil, for pancreatic cancer.

[View original record](https://reporter.nih.gov/search/J7l2tQ4hHkqRePwGq3m5kA/project-details/11625594)